Exane Derivatives’s Paramount Group PGRE Stock Holding History

Exane Derivatives’s Portfolio PGRE Stock Details PGRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$513	Hold	71	–	–	﹤0.01%	566
2022 Q1	$775	Hold	71	–	–	﹤0.01%	827
2021 Q4	$592	Hold	71	–	–	﹤0.01%	754
2021 Q3	$638	Hold	71	–	–	﹤0.01%	913
2021 Q2	$709	Hold	71	–	–	﹤0.01%	910
2021 Q1	$719	Hold	71	–	–	﹤0.01%	760
2020 Q4	$642	Sell	71 -1,333	-95%	-$10.7K	﹤0.01%	719
2020 Q3	$9.94K	Sell	1,404 -15,366	-92%	-$112K	﹤0.01%	464
2020 Q2	$129K	Buy	16,770 +983	+6%	+$8.29K	0.03%	256
2020 Q1	$139K	Buy	15,787 +481	+3%	+$5.96K	0.04%	241
2019 Q4	$215K	Sell	15,306 -1,033	-6%	-$13.9K	0.04%	249
2019 Q3	$218K	Buy	16,339 +2,561	+19%	+$34.5K	0.04%	241
2019 Q2	$193K	Buy	+13,778	New	+$199K	0.03%	279

Other funds holding PGRE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

MAC

Monarch Alternative Capital New York $1.63B AUM 125.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Exane Derivatives's PGRE Position: Q2 2022 in Review

Exane Derivatives held its Paramount Group (PGRE) position steady in Q2 2022 at 71 shares worth $513. The position accounts for ﹤0.01% of the portfolio, ranked #566.

Exane Derivatives first reported a position in PGRE in Q2 2019 and has held it in 13 quarters since. The position peaked at $218K in Q3 2019. 185 funds tracked by Wall St. Rank hold PGRE as of Q2 2022.

Exane Derivatives held 71 shares of Paramount Group worth $513 as of Q2 2022.
Exane Derivatives left its Paramount Group share count unchanged in Q2 2022.
Paramount Group made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #566 holding.
Exane Derivatives first reported a position in Paramount Group in Q2 2019 and has held it in 13 quarters since.
Exane Derivatives's Paramount Group position peaked at $218K in Q3 2019.
185 funds tracked by Wall St. Rank held Paramount Group as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.